Public Willingness to Undergo Presymptomatic Genetic Testing for Alzheimer’s Disease

Table 3

Participants’ perception about presymptomatic genetic testing for Alzheimer’s disease (total number of participants =2935).

Participants’ perception about presymptomatic genetic testing for autosomal dominant AD genes, APOE, or both.	Number (%)
Accepting either genetic tests	1758 (59.9)
Accepting both genetic tests	1325 (45.1)
Accepting autosomal dominant AD genetic test	1560 (53.2)
Accepting APOE gene test	1523 (51.9)
Rejecting both tests	1177 (40.1)